pf-06882961
Showing 1 - 8 of 8
Healthy Adults Trial in Anaheim (PF-06882961, Atorvastatin, Midazolam)
Completed
- Healthy Adults
- PF-06882961
- +3 more
-
Anaheim, CaliforniaAnaheim Clinical Trials, LLC
Jul 21, 2022
Type 2 Diabetes Trial in Hachioji (Placebo, PF-06882961)
Completed
- Type 2 Diabetes Mellitus
- Placebo
- PF-06882961
-
Hachioji, Tokyo, JapanP-one clinic, Keikokai medical corporation
Mar 10, 2022
Diabetes, Type 2 Trial in Beijing (PF-06882961, Placebo)
Completed
- Diabetes Mellitus, Type 2
- PF-06882961
- Placebo
-
Beijing, ChinaPeking University Third Hospital
Mar 10, 2022
Obesity Trial in Anaheim (PF-06882961, Rosuvastatin, Midazolam)
Completed
- Obesity
- PF-06882961
- +2 more
-
Anaheim, CaliforniaAnaheim Clinical Trials, LLC
Jun 3, 2021
Obesity Trial in Worldwide (Placebo, PF-06882961)
Active, not recruiting
- Obesity
- Placebo
- PF-06882961
-
Anniston, Alabama
- +40 more
Jun 29, 2022
Type 2 Diabetes Trial in Anaheim, South Miami, Overland Park (Placebo, PF-06882961)
Completed
- Type 2 Diabetes Mellitus
- Placebo
- PF-06882961
-
Anaheim, California
- +3 more
Jun 17, 2020
Healthy Subjects Trial in New Haven (PF-06882961, Placebo)
Completed
- Healthy Subjects
- PF-06882961
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Mar 30, 2018